EP Patent

EP1385518A1 — Benzimidazolone compounds

Assigned to Euro Celtique SA · Expires 2004-02-04 · 22y expired

What this patent protects

Disclosed are compounds of the formula (I): wherein A, B, C, M1-M4, R, R1, R2 and n are as described herein.

USPTO Abstract

Disclosed are compounds of the formula (I): wherein A, B, C, M1-M4, R, R1, R2 and n are as described herein.

Drugs covered by this patent

Patent Metadata

Patent number: EP1385518A1
Jurisdiction: EP
Classification: —
Expires: 2004-02-04
Drug substance claim: No
Drug product claim: No
Assignee: Euro Celtique SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.